[The Copenhagen Peace Congress and physicians]

UV absorption of Criegee intermediates: quantitative cross sections from high-level ab initio theory.

Physical chemistry chemical physics : PCCP·2018

Allelic heterogeneity of alkaptonuria in Central Europe.

European journal of human genetics : EJHG·1999

[Congenital developmental defects of the cardiovascular system from the aspect of genetic factors and dysmorphogenesis].

Bratislavske lekarske listy·1999

Molecular defects in alkaptonuria.

Cytogenetics and cell genetics·1997

The human gene for alkaptonuria (AKU) maps to chromosome 3q.

Genomics·1994

[Disorders of the cardiovascular system in congenital lentiginosis].

Ceskoslovenska pediatrie·1991

[Growth, development and prediction of body height in children with central precocious puberty after 3 years of therapy with Decapeptyl-Depot, a slow-releasing GnRH agonist].

Ceskoslovenska pediatrie·1994

[Dangers in external treatment of skin diseases in childhood].

Ceskoslovenska pediatrie·1994

[The effect of growth hormone therapy on thyroid parameters].

Ceskoslovenska pediatrie·1994

[Long-term therapy of central precocious puberty in girls with the gonadoliberin analog D-Trp-6-LHRH after prior therapy with cyproterone acetate].

Ceskoslovenska pediatrie·1994

[Improvement in the prognosis for growth in a boy with central precocious puberty and growth hormone deficiency treated concurrently with growth hormone and D-Trp-6-LHRH gonadoliberin analog].

Ceskoslovenska pediatrie·1994

[D-Trp-6 gonadotropin analog releasing hormone (Decapeptyl-Depot)-- the drug of choice in central idiopathic precocious puberty].

Ceskoslovenska pediatrie·1994

Preexisting cardiovascular disease and inpatient arrhythmias after autologous stem cell transplantation for multiple myeloma: a National Inpatient Sample analysis.

Proceedings (Baylor University. Medical Center)·2026

Risk factors for recurrent cardiovascular events in CKD: results from the KNOW-CKD study.

Journal of nephrology·2026

Optimizing hyperkalemia management in CKD: real-world nephrologist strategies and impact on patient outcomes.

Journal of nephrology·2026

Temporal Trends in Mortality Due to Ischemic Heart Disease and Cardiac Arrhythmias in the United States From 1999 to 2023.

Clinical cardiology·2026

Clinical value of hsa_circ_0003254 in postmenopausal osteoporosis and its role in the progression of osteoporosis.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026

Metabolic Burden and Hyperuricemia Are Associated With CKD-Related Outcomes in Individuals With and Without Steatotic Liver Disease.

Hepatology research : the official journal of the Japan Society of Hepatology·2026

Related Experiment Videos

[The Copenhagen Peace Congress and physicians]

Related Concept Videos

UV absorption of Criegee intermediates: quantitative cross sections from high-level ab initio theory.

Allelic heterogeneity of alkaptonuria in Central Europe.

[Congenital developmental defects of the cardiovascular system from the aspect of genetic factors and dysmorphogenesis].

Molecular defects in alkaptonuria.

The human gene for alkaptonuria (AKU) maps to chromosome 3q.

[Disorders of the cardiovascular system in congenital lentiginosis].

[Growth, development and prediction of body height in children with central precocious puberty after 3 years of therapy with Decapeptyl-Depot, a slow-releasing GnRH agonist].

[Dangers in external treatment of skin diseases in childhood].

[The effect of growth hormone therapy on thyroid parameters].

[Long-term therapy of central precocious puberty in girls with the gonadoliberin analog D-Trp-6-LHRH after prior therapy with cyproterone acetate].

[Improvement in the prognosis for growth in a boy with central precocious puberty and growth hormone deficiency treated concurrently with growth hormone and D-Trp-6-LHRH gonadoliberin analog].

[D-Trp-6 gonadotropin analog releasing hormone (Decapeptyl-Depot)-- the drug of choice in central idiopathic precocious puberty].

Preexisting cardiovascular disease and inpatient arrhythmias after autologous stem cell transplantation for multiple myeloma: a National Inpatient Sample analysis.

Risk factors for recurrent cardiovascular events in CKD: results from the KNOW-CKD study.

Optimizing hyperkalemia management in CKD: real-world nephrologist strategies and impact on patient outcomes.

Temporal Trends in Mortality Due to Ischemic Heart Disease and Cardiac Arrhythmias in the United States From 1999 to 2023.

Clinical value of hsa_circ_0003254 in postmenopausal osteoporosis and its role in the progression of osteoporosis.

Metabolic Burden and Hyperuricemia Are Associated With CKD-Related Outcomes in Individuals With and Without Steatotic Liver Disease.

Related Experiment Videos

[The Copenhagen Peace Congress and physicians]

Related Concept Videos

Related Articles